- Home
- CRGY vs ACAD Comparison
CRGY vs ACAD Comparison
Compare CRGY & ACAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRGY
- ACAD
- Stock Information
- Founded
- CRGY 1986
- ACAD 1993
- Country
- CRGY United States
- ACAD United States
- Employees
- CRGY N/A
- ACAD N/A
- Industry
- CRGY Oil & Gas Production
- ACAD Biotechnology: Pharmaceutical Preparations
- Sector
- CRGY Energy
- ACAD Health Care
- Exchange
- CRGY Nasdaq
- ACAD Nasdaq
- Market Cap
- CRGY 2.8B
- ACAD 3.4B
- IPO Year
- CRGY N/A
- ACAD 2004
- Fundamental
- Price
- CRGY $14.26
- ACAD $19.95
- Analyst Decision
- CRGY Buy
- ACAD Buy
- Analyst Count
- CRGY 11
- ACAD 19
- Target Price
- CRGY $17.89
- ACAD $25.33
- AVG Volume (30 Days)
- CRGY 2.1M
- ACAD 1.6M
- Earning Date
- CRGY 02-26-2025
- ACAD 02-26-2025
- Dividend Yield
- CRGY 3.35%
- ACAD N/A
- EPS Growth
- CRGY 42.32
- ACAD N/A
- EPS
- CRGY 0.53
- ACAD 0.78
- Revenue
- CRGY $2,713,358,000.00
- ACAD $929,236,000.00
- Revenue This Year
- CRGY $25.49
- ACAD $36.88
- Revenue Next Year
- CRGY $31.44
- ACAD $8.01
- P/E Ratio
- CRGY $27.04
- ACAD $25.70
- Revenue Growth
- CRGY 12.60
- ACAD 47.06
- 52 Week Low
- CRGY $9.88
- ACAD $14.15
- 52 Week High
- CRGY $16.94
- ACAD $26.56
- Technical
- Relative Strength Index (RSI)
- CRGY 37.57
- ACAD 60.25
- Support Level
- CRGY $14.29
- ACAD $19.52
- Resistance Level
- CRGY $15.58
- ACAD $20.29
- Average True Range (ATR)
- CRGY 0.51
- ACAD 0.68
- MACD
- CRGY -0.07
- ACAD 0.08
- Stochastic Oscillator
- CRGY 6.38
- ACAD 72.62
About CRGY Crescent Energy Company
Crescent Energy Co is an independent energy company with a portfolio of assets in key basins across the lower 48 states. The company maintains a diverse portfolio of assets in key basins across the United States, including the Eagle Ford, Rockies, Barnett, Permian, and Mid-Con. It seeks to deliver attractive risk-adjusted investment returns and predictable cash flows across cycles with a focus on operated oil and gas assets complemented by non-operated assets, mineral and royalty interests, and midstream infrastructure.
About ACAD ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecules drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.